The COVID -Recovery Study

ANZICS CTG Endorsed Study

The COVID -Recovery Study

Study Description

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus that emerged in 2019 and causes Coronavirus Disease 2019 (COVID-19). The rates of admission to an intensive care unit (ICU) are approximately 5% and the long-term outcomes of these patients are unknown. In order to improve quality of life of ICU survivors and ensure that physiotherapists apply appropriate treatment to reduce the cost of these surviving patients on the community, COVID-Recovery will conduct a longitudinal cohort study.

Management Committee

Carol Hodgson, Scott Bradley, Lisa Beach, Bernie Bissett, Ianthe Boden, Kimberley Haines, Lisa Higgins, Alice Jones, Lisa van der Lee, Marc Nickels, George Ntoumenopoulos, Thomas Rollinson, Shane Patman, Michelle Paton, Gemma Pound, Janani Sivasuthan, Peter Thomas, Claire Tipping

Administering Institution

Monash University – Australian and New Zealand Intensive Care Research Centre Department of Epidemiology and Preventive Medicine

Sample Size

300 patients

Project Status 





Carol Hodgson email